Dantrium and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Dantrium (dantrolene sodium), especially for people who are male, 60+ old, also take Ceftin, and have Primary progressive multiple sclerosis.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Dantrium. It is created by eHealthMe based on reports of 1,397 people who have side effects when taking Dantrium from the FDA, and is updated regularly.

What is Dantrium?

Dantrium has active ingredients of dantrolene sodium. eHealthMe is studying from 1,408 Dantrium users. Check the latest studies of Dantrium.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 944 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

On Jul, 20, 2026

1,397 people reported to have side effects when taking Dantrium.
Among them, 11 people (0.79%) have Thrombophlebitis.

Among these 11 people:

What is the gender of people who have Thrombophlebitis when taking Dantrium? *

female: 20 %
male: 80 %

What is the age of people who have Thrombophlebitis when taking Dantrium? *

What are other drugs people take besides Dantrium? *

What are other side effects people have besides Thrombophlebitis? *

Fatigue (feeling of tiredness): 5 people, 45.45%
Oedema Lower Limb (fluid collection in tissue of lower leg): 5 people, 45.45%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 36.36%
Chest Pain: 3 people, 27.27%
Oedema Upper Limb (swelling of arm): 3 people, 27.27%
Venous Thrombosis Deep Limb (blood clot that forms in a vein deep in the limb): 3 people, 27.27%
Distress: 3 people, 27.27%
Coughing Up Blood: 3 people, 27.27%
Drug Ineffective: 2 people, 18.18%
Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 2 people, 18.18%

What are the existing conditions these people have? *

Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 18.18%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 1 person, 9.09%
Hyperpyrexia Malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dantrium and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dantrium:

Dantrium (1,408 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Dantrium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (944 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dantrolene sodium (the active ingredients of Dantrium) and Dantrium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.